Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
09/1995
09/14/1995WO1995024200A1 Method for treating 5ht2b receptor related conditions
09/14/1995WO1995024194A1 Treatment of obsessive-compulsive disorders with 5-ht2 antagonists
09/14/1995WO1995024191A1 8-substituted tetrahydro-beta-carbolines
09/14/1995WO1995024189A1 Increasing fetal hemoglobin levels using carboxylic esters
09/14/1995WO1995024186A1 Sulfonamide derivatives and their use
09/14/1995WO1995024182A1 Human osteoclast-derived cathepsin
09/14/1995CA2443236A1 Human osteoclast-derived cathepsin
09/14/1995CA2414016A1 Vascular endothelial growth factor 2
09/14/1995CA2185236A1 Method for treating 5ht2b receptor related conditions
09/14/1995CA2185235A1 8-substituted tetrahydro-beta-carbolines
09/14/1995CA2185229A1 Polymer-conjugated malonic acid derivatives and their use as medicaments and diagnostic agents
09/14/1995CA2185162A1 Compositions for the inhibition of tnf formation and uses thereof
09/14/1995CA2185104A1 Naphthalene derivatives as prostaglandin 12 agonists
09/14/1995CA2184905A1 Corpuscles of stannius protein, stanniocalcin
09/14/1995CA2184824A1 Bradykinin antagonist peptides incorporating n-substituted glycines
09/14/1995CA2184695A1 Increasing fetal hemoglobin levels using carboxylic esters
09/14/1995CA2184583A1 Transforming growth factor alpha h1
09/14/1995CA2183961A1 Fibroblast growth factor-10
09/14/1995CA2183653A1 Sulphonamide derivatives as aspartyl protease inhibitors
09/14/1995CA2183428A1 Sulfonamide derivatives and their use
09/14/1995CA2182800A1 Method of stimulating hematopoiesis with hemoglobin
09/13/1995EP0671409A2 Malonic acid derivatives having anti-adhesive properties
09/13/1995EP0671408A2 Carbohydrate mimetics having anti-adhesive properties
09/13/1995EP0671407A2 Sulfated alpha-glycolipid derivatives as cell adhesion inhibitors
09/13/1995EP0671406A2 Sulfated beta-glycolipid derivatives as cell adhesion inhibitors
09/13/1995EP0671397A1 Alkylaminoindanes compounds, processes for their preparation and pharmaceutical compositions containing them
09/13/1995EP0671171A1 Use of HMG COA reductase inhibitor for the manufacture of a medicament for proventing or reducing risks of onset of cardiovascular events
09/13/1995EP0671160A1 Use of sulphonic acids as antiageing agents in cosmetic and/or dermatological compositions
09/13/1995EP0671156A1 Cosmetic or pharmaceutical compositions containing liposomes
09/13/1995EP0671005A1 Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression
09/13/1995EP0670904A1 Vector for the expression of therapy-relevant genes
09/13/1995EP0670898A1 Interleukin-3 (il-3) mutant polypeptides
09/13/1995EP0670839A1 Process for the preparation of 9-amino camptothecin
09/13/1995EP0670826A1 Fatty acid derivatives and pharmaceutical compositions containing them
09/13/1995EP0670730A1 Fusion proteins comprising tumor necrosis factor receptor
09/13/1995EP0670727A1 Compounds that inhibit t cell proliferation and methods using the same
09/13/1995EP0670720A1 Enzyme inhibitors
09/13/1995EP0670719A1 Combination of atovaquone with proguanil for the treatment of protozoal infections
09/13/1995EP0541593B1 Cyclopentane derivatives, process for producing them and their pharmaceutical use
09/13/1995EP0383770B1 Inhibition of eucaryotic pathogens and neoplasms with lytic peptides
09/13/1995CN1108456A Benzothiazole compound, process for producing the same, and use thereof
09/13/1995CN1108257A Heterocyclically substituted phenyl-cyclohexane-carboxylic acid derivatives
09/13/1995CN1108254A Process for the preparation of alpha-tocopherol derivatives
09/13/1995CN1108247A Compounds
09/13/1995CN1108244A Lactone compound and process of production thereof
09/13/1995CN1108098A Methods of inhibiting alzheimer's disease
09/13/1995CN1108096A Non-peptide tachykinin receptor antagonists
09/13/1995CN1108092A Methods of increasing macrophage function
09/13/1995CN1108090A Methods for inhibiting LDL oxidation and atherosclerosis
09/12/1995US5449798 Phospholipid derivatives containing higher elements of the fifth group
09/12/1995US5449692 Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation
09/12/1995US5449674 Prostaglandin E2 inhibitors
09/12/1995US5449661 Angiotensin converting enzyme inhibitor and method for preparing same
09/12/1995US5449522 Antitumor
09/12/1995US5449355 Retrograde tissue splitter and method
09/12/1995US5448898 Air treatment plant for foodstuff comprising a trough with an adjustable width
09/12/1995EP0680318A4 Method for increasing the efficiency of feed conversion in animals.
09/12/1995CA2144390A1 Malonic acid derivatives having antiadhesive properties
09/12/1995CA2144388A1 Carbohydrate mimetics having antiadhesive properties
09/12/1995CA2144288A1 Alkylaminoindans compounds; process for preparing the same and pharmaceutical compositions containing them
09/12/1995CA1336978C Bisphosphonates
09/12/1995CA1336961C Long lasting composition of propafenone and quinidine for treatment of cardiac conditions
09/12/1995CA1336953C Method of preventing or reducing adverse reactions to protamine using a thromboxane a _receptor antagonist
09/11/1995CA2144019A1 Tetrazolyphenyl pivalate derivatives and medicinal composition containing the same as effective component
09/08/1995WO1995023857A1 Yeast strains and modified albumins
09/08/1995WO1995023790A1 Cytokine inhibiting imidazole substituted hydroxamic acid derivatives
09/08/1995WO1995023789A1 Bicyclic carbamates as leukotriene d4 antagonists
09/08/1995WO1995023783A1 Ketopanthenol with acetylating properties
09/08/1995WO1995021927A3 Targeting gene therapy
09/08/1995CA2183752A1 Ketopanthenol with acetylating properties
09/06/1995EP0670369A2 A novel peptide related to human programmed cell death and DNA encoding it
09/06/1995EP0670330A1 Long-chain alkylamides of aminoacids and peptides with antiproliferative and antiinflammatory properties
09/06/1995EP0670318A2 Acetamides with analgesic and neuroprotective activity
09/06/1995EP0670163A1 Use of pentoxifylline for the manufacture of a medicament for the treatment of fibrosing or granulomatosing lung diseases
09/06/1995EP0670162A1 Pharmaceutical formulations containing raloxifere, a surfactant and a watersoluble diluent
09/06/1995EP0669937A1 Peptide inhibitors of fibronectin and related collagen-binding proteins
09/06/1995EP0669936A1 Novel mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace
09/06/1995EP0669919A1 Use of dimethylbenzofurans and dimethylbenzopyrans as 5-ht3 antagonists
09/06/1995EP0669914A1 Novel isoxazolines as antiinflammatory agents
09/06/1995EP0669909A1 Substituted amidino compounds, their manufacture and methods of treatment
09/06/1995EP0669830A1 Substituted dipeptide analogs promote release of growth hormone
09/06/1995EP0669827A1 Compositions for the regulation of cytokine activity
09/06/1995EP0617958A4 Pharmaceutical composition having anti-alcohol, radioprotecting and anti-choleraic activity and stimulating energy metabolism, stomach mucous membrane acid-generation and secretion functions.
09/06/1995EP0509027B1 A process to correct and optimize the composition of a feed
09/06/1995EP0478721B1 New benzocycloalkene carboxylic acid and process for producing it
09/06/1995EP0317627B1 Oncogene-encoded polypeptide having growth factor activity and methods of production and use thereof
09/06/1995CN1107839A Carbox amide
09/06/1995CN1107704A Methods of inhibiting thrombin
09/06/1995CN1107703A Methods of inhibiting hirsutism and alopecia in women
09/06/1995CN1107700A Melatonin derivatives for use in terating desynchronization disorders
09/06/1995CN1107699A Treatment of incontinence
09/05/1995US5447959 Vitamin A derivatives
09/05/1995US5447954 Antilipidemic agents
09/05/1995US5447951 Use of 3-indolepyruvic acid or its salt
09/05/1995US5447929 Collagenase inhibitors for degenerative joint disease, antitumor agents or atherosclerosis
09/05/1995US5447924 Vitamin D analogues
09/05/1995US5447852 DNA encoding cyclophilin C, and recombinant methods employing it
09/05/1995US5447719 β-glucuronidase inhibitor
09/05/1995CA2142154A1 Sulfated .alpha.-glycolipid derivatives as cell adhesion inhibitors
09/05/1995CA2142153A1 Sulfated .beta.-glycolipid derivatives as cell adhesion inhibitors